Additionally, a recent study on head and neck cancer found that high Drp1 expression was linked to increased cell motility and metastatic characteristics, suggesting Drp1 as a potential prognostic marker and target for therapy in head and neck cancer patients [38]. This evidence concerns the gene DENR and head and neck cancer.